Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-051207
Filing Date
2024-12-23
Accepted
2024-12-23 07:50:45
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1253162
2 ex10-1.htm EX-10.1 25262
3 ex10-2.htm EX-10.2 3265
4 ex31-1.htm EX-31.1 18362
5 ex31-2.htm EX-31.2 18348
6 ex32-1.htm EX-32.1 7905
7 ex32-2.htm EX-32.2 8075
8 ex10-2_001.jpg GRAPHIC 1737699
9 ex10-2_002.jpg GRAPHIC 74832
  Complete submission text file 0001493152-24-051207.txt   9648541

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ocea-20240331.xsd EX-101.SCH 62278
11 XBRL CALCULATION FILE ocea-20240331_cal.xml EX-101.CAL 51226
12 XBRL DEFINITION FILE ocea-20240331_def.xml EX-101.DEF 338636
13 XBRL LABEL FILE ocea-20240331_lab.xml EX-101.LAB 441837
14 XBRL PRESENTATION FILE ocea-20240331_pre.xml EX-101.PRE 384918
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1076773
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40793 | Film No.: 241569894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)